These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation. Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361 [TBL] [Abstract][Full Text] [Related]
6. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome. Jorkjend L; Bergenholtz A; Johansson AK; Johansson A Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802 [TBL] [Abstract][Full Text] [Related]
8. Opposite effects of antidepressants on unstimulated and stimulated salivary flow. Kopittke L; Gomez R; Barros HM Arch Oral Biol; 2005 Jan; 50(1):17-21. PubMed ID: 15598413 [TBL] [Abstract][Full Text] [Related]
9. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study. Brimhall J; Jhaveri MA; Yepes JF Spec Care Dentist; 2013; 33(3):123-7. PubMed ID: 23600983 [TBL] [Abstract][Full Text] [Related]
11. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Fox PC; Atkinson JC; Macynski AA; Wolff A; Kung DS; Valdez IH; Jackson W; Delapenha RA; Shiroky J; Baum BJ Arch Intern Med; 1991 Jun; 151(6):1149-52. PubMed ID: 2043017 [TBL] [Abstract][Full Text] [Related]
12. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome. Khurshudian AV Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025 [TBL] [Abstract][Full Text] [Related]
13. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133 [TBL] [Abstract][Full Text] [Related]
15. Salivation triggered by pilocarpine involves aquaporin-5 in normal rats but not in irradiated rats. Asari T; Maruyama K; Kusama H Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):531-8. PubMed ID: 19673936 [TBL] [Abstract][Full Text] [Related]
16. Effects of furosemide and bendroflumethiazide on saliva flow rate and composition. Nederfors T; Nauntofte B; Twetman S Arch Oral Biol; 2004 Jul; 49(7):507-13. PubMed ID: 15126132 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of pilocarpine and cevimeline on salivary flow. Braga MA; Tarzia O; Bergamaschi CC; Santos FA; Andrade ED; Groppo FC Int J Dent Hyg; 2009 May; 7(2):126-30. PubMed ID: 19416095 [TBL] [Abstract][Full Text] [Related]
18. Studies on the prevalence of reduced salivary flow rate in relation to general health and dental caries, and effect of iron supplementation. Flink H Swed Dent J Suppl; 2007; (192):3-50, 2 p preceding table of contents. PubMed ID: 18274060 [TBL] [Abstract][Full Text] [Related]
19. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer. Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571 [TBL] [Abstract][Full Text] [Related]
20. Effect of pilocarpine on substance P and calcitonin gene-related peptide releases correlate with salivary secretion in human saliva and plasma. Sato Y; Itoh H; Suzuki Y; Tatsuta R; Takeyama M J Clin Pharm Ther; 2013 Feb; 38(1):19-23. PubMed ID: 23030252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]